PA 2120 (Valproic acid 250 mg)
Pill imprint PA 2120 has been identified as Valproic acid 250 mg.
Valproic acid is used in the treatment of bipolar disorder; epilepsy; schizoaffective disorder; migraine prevention; seizures (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Valproic acid 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- PA 2120
- Strength:
- 250 mg
- Color:
- White
- Size:
- 19.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Fatty acid derivative anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk - When treating epilepsy
X - Not for use in pregnancy - When treating migraine - CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 50111-0852
- Inactive Ingredients:
- corn oil
FD&C Blue No. 1
gelatin
glycerin
water
titanium dioxide
More about valproic acid
Consumer resources
- Valproate
- Valproate Syrup
- Valproic acid
- Valproic acid delayed-release capsules
- Valproic acid syrup
- Valproic acid (Advanced Reading)
- Other brands: Depakene, Valproate Sodium, Depacon, Stavzor
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
